Delivery Order SPE2DB24D2013-SPE2DB24FCHSD
Award Date
9/26/24
Potential Completion Date
9/27/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,303.57 firm-fixed-price contract is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,135.20, is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $4,036.04 and a performance period ending on September 27, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,077.50, is for the delivery of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has a completion date of January 15, 2025 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 1 MG TABLET 30S, a prescription medication, with a ceiling value of $2,655.96 and a period of performance through August 13, 2024. The contract was awarded on August 12, 2024 and is a firm fixed-price, delivery order contract with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a prescription medication. The award has a firm fixed price, a ceiling value of $6,103.11, and an ultimate completion date of June 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $37,571.13 and is a firm-fixed price arrangement with an ultimate completion date of August 23, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which is valued at up to $999,999,999 and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,230.39 contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 14, 2024 and is a Firm Fixed Price contract. There is no set-aside designation mentioned for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a $1,959.96 firm fixed price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $8,633.19, is for the delivery of the pharmaceutical product REXULTI 2 MG TABLET 30S. The contract has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...